Westlake Chemical Partners LP
NYSE:WLKPChemicals
-$0.07 today
- Market cap
- $743.49M
- Beta
- 0.50
- P/E (TTM)
- 6.3
- EPS (TTM)
- $3.60
- Dividend yield
- 8.31%
Volume 0.01M
Average 0.03M
WLKP Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Westlake Chemical Partners LPNYSE: WLKP
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How WLKP compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for WLKP, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.89M USD | -22.2% | -3.5% | 4891.2% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | PEN 0 PEN | — | — | 0.0% | |
| LTM Apr 2026 | $0 USD | — | +4.5% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
LARLithium Argentina AG | LTM Mar 2026 | $0 USD | — | — | — |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | +7.7% | 0.0% | |
| Peer median (excluding WLKP) | — | -100.0% | +4.5% | 0.0% | |
Competitors are the stored peer set for WLKP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.21B | 1.59B | 1.19B | 1.14B | 1.17B |
| Cost of Revenue | 773.15M | 1.22B | 803.33M | 716.96M | 818.85M |
| Gross Profit | 441.71M | 377.37M | 387.46M | 418.94M | 347.85M |
| Gross Margin | 36.4% | 23.7% | 32.5% | 36.9% | 29.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 31.02M | 29.68M | 29.75M | 28.5M | 28.27M |
| Operating Expenses | 31.02M | 29.68M | 29.75M | 28.5M | 28.27M |
| Depreciation & Amortization | 108.81M | 121.07M | 110.2M | 111.9M | 127.98M |
| EBITDA | 519.56M | 470.33M | 472.14M | 507.59M | 450M |
| EBITDA Margin | 42.8% | 29.5% | 39.6% | 44.7% | 38.6% |
| Operating Income | 410.69M | 347.69M | 357.71M | 390.44M | 319.58M |
| Operating Margin | 33.8% | 21.8% | 30.0% | 34.4% | 27.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 8.82M | 13.41M | 26.5M | 25.7M | 22.9M |
| Other Income / Expenses | (8.75M) | (11.84M) | (22.27M) | (20.45M) | (20.45M) |
| Income Before Tax | 401.93M | 335.85M | 335.44M | 369.99M | 299.12M |
| Pre-Tax Margin | 33.1% | 21.1% | 28.2% | 32.6% | 25.6% |
| Income Tax Expense | 549K | 1.02M | 813K | 835K | 547K |
| Net Income | 82.55M | 64.17M | 54.28M | 62.39M | 298.58M |
| Net Margin | 6.8% | 4.0% | 4.6% | 5.5% | 25.6% |
| EPS (Basic) | 2.34 | 1.82 | 1.54 | 1.77 | 8.47 |
| EPS (Diluted) | 2.34 | 1.82 | 1.54 | 1.77 | 8.47 |
| Weighted Avg Shares | 35.21M | 35.22M | 35.25M | 35.23M | 35.23M |
| Weighted Avg Shares (Diluted) | 35.21M | 35.22M | 35.22M | 35.23M | 35.23M |
Westlake Chemical Partners LP
NYSE:WLKP
Intrinsic Alpha fair value
Locked
Current Price
$21.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.